Access the 4th TGF-β Targeted Drug Development Summit Agenda Here!

Download the full event guide to browse 3 days of TGF-β content exploring strategic insights to overcome translatability of your animal models to humans, re-evaluate your clinical trial design using predictive and pharmacodynamic biomarkers for patient identification, and unlock TGF-β targeting to bring these therapies to patients faster for precision oncology, fibrosis, autoimmune diseases and beyond...

Here's what to expect: 

  • 18+ TGF-β expert speakers
  • 67% Brand New Speaking Companies such as AbbVie, Pfizer, Oncotelic Therapeutics, & Amgen
  • 35% of Content Exploring TGF-β Beyond Oncology
  • 6+ Hours of Interactive Networking
  • 2 Deep Dive Workshops on Designing the Most Effective Clinical Trials for TGF-β Targeted
    Therapies Toward Clinical Efficacy, and Avoiding the Pitfalls in Targeting TGF-β to Achieve Better Specificity,
    Reduced Toxicity & More Effective Treatments 

Having trouble downloading the brochure? Let us know and we’ll email it to you instead